Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later ‐line nivolumab monotherapy—The Asahikawa Gastric Cancer Cohort Study (AGCC)

ConclusionsThe regional cohort study of nivolumab monotherapy for gastric cancer patients revealed prognostic factors and a nomogram was developed that could predict the probability of survival.

Source: Cancer Medicine - November 30, 2021 Category: Cancer & Oncology Authors: Kazuyuki Tanaka, Hiroki Tanabe, Hiroki Sato, Chisato Ishikawa, Mitsuru Goto, Naoyuki Yanagida, Hiromitsu Akabane, Shiro Yokohama, Kimiharu Hasegawa, Yohei Kitano, Yuya Sugiyama, Kyoko Uehara, Yu Kobayashi, Yuki Murakami, Takehito Kunogi, Ta Tags: RESEARCH ARTICLE Source Type: research